Menu Search
Equities

Endo Inc

NDOI:QXR

Endo Inc

Actions
  • Price (USD)24.50
  • Today's Change-0.55 / -2.20%
  • Shares traded400.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 14:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Endo Inc had revenues fall -13.25% from 2.32bn to 2.01bn, though the company grew net income from a loss of 2.92bn to a smaller loss of 2.45bn.
Gross margin--
Net profit margin--
Operating margin--
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2023, cash reserves at Endo Inc fell by 218.62m. However, the company earned 435.10m from its operations for a Cash Flow Margin of 21.63%. In addition the company used 49.79m on investing activities and also paid 604.63m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share23.99
Tangible book value per share23.99
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.